Cvi Investments is Buying Neuralstem Inc. (NASDAQ:CUR) Shares


In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Neuralstem Inc. (NASDAQ:CUR) reported that Cvi Investments, Inc. has picked up 1,250,000 of common stock as of 2017-08-07.

The acquisition brings the aggregate amount owned by Cvi Investments, Inc. to a total of 1,250,000 representing a 8.3% in the company.

For those not familiar with the company, Neuralstem, Inc. (Neuralstem) is a clinical-stage biopharmaceutical company. The Company is engaged in research, development and commercialization of central nervous system therapies based on its human neuronal stem cells and its stem-cell derived small molecule compounds. The Company has approximately three assets: its NSI-189 small molecule program, its NSI-566 stem cell therapy program and its chemical entity screening platform. The Company’s technology allows the commercial-scale production of multiple types of central nervous system stem cells, which are under development for the treatment of central nervous system diseases and conditions. The Company is developing NSI-189 for the treatment of major depressive disorder (MDD) and other psychiatric and/or cognitive impairment indications associated with hippocampal atrophy. The Company’s NSI-566 is indicated for amyotrophic lateral sclerosis (ALS), chronic spinal cord injury and motor deficits due to ischemic stroke.

A glance at Neuralstem Inc. (NASDAQ:CUR)’s key stats reveals a current market capitalization of 19.07M based on 15.01M shares outstanding and a price at last close of 1.27.

Looking at insider activity, there are a few recent transactions worth noting.

Specifically, on 2017-05-17, Daly picked up 7,500 at a purchase price of $4.00 per share.This brings their total holding to 23,312 as of the date of the filing.

On the sell side, the most recent transaction saw Johe unload 25,000 shares at a sale price of $1.09. This brings their total holding to 826,304.

It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Neuralstem Inc. (NASDAQ:CUR) as things move forward to see if its progress aligns with these transactions. Subscribe below and we’ll keep you on top of what’s happening before it moves markets.